Linking central sensitization to multisystemic manifestations in hypermobile Ehlers-Danlos syndrome - Report - MDSpire

Linking central sensitization to multisystemic manifestations in hypermobile Ehlers-Danlos syndrome

  • By

  • Ana Paula Montemayor Zarazúa

  • César Vidal Elizondo Solis

  • Camila Ayala García

  • Diego Jesús Pacheco Estrella

  • Octavio Ilizaliturri Guerra

  • Ana Cecilia Arana Guajardo

  • Emma Purón Gonzalez

  • Karina Silva Luna

  • Luis Iván Lozano Plata

  • Mario Ramon García Pompermayer

  • Mario Alberto Garza Elizondo

  • June 30, 2026

  • 0 min

Share

Clinical Report: Examining the Relationship Between Central Sensitization and Diverse Symptoms in Hypermobile Ehlers-Danlos Syndrome

Overview

This study investigates the association between central sensitization (CS) and symptom burden in patients with hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders (HSD). It identifies fatigue, pain, and cardiac dysautonomia as independent predictors of CS in this population.

Background

Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders (HSD) are complex conditions often associated with chronic pain and a variety of multisystemic symptoms. Central sensitization (CS) may explain the heightened sensitivity and diverse symptoms experienced by these patients.

Data Highlights

CharacteristicValue
Number of participants150
Centrally sensitized patients76
Independent predictors of CSFatigue (OR 1.089), Pain (OR 1.067), Cardiac Dysautonomia (OR 1.057)
CSI score correlation with SPIDER domainsp < 0.001
AUC of multivariable logistic regression model0.98

Key Findings

  • Centrally sensitized patients were significantly younger and predominantly female.
  • CSI scores correlated strongly with all eight domains of the SPIDER questionnaire.
  • Fatigue, pain, and cardiac dysautonomia were identified as independent predictors of CS.
  • CS in hEDS/HSD is associated with a triad of fatigue, pain, and cardiac dysautonomia.

Clinical Implications

The identification of fatigue, pain, and cardiac dysautonomia as predictors of central sensitization can guide clinicians in assessing and managing patients with hEDS/HSD.

Conclusion

This study highlights the significant relationship between central sensitization and symptom burden in hEDS/HSD.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Clinical Rheumatology, 2020 -- Systematic Review of Tissue Mechanics Measurements for Identifying Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders
  3. Clinical Rheumatology, 2024 -- The Spider Questionnaire: Validation of a Visual Tool for Assessing Multisystemic Symptoms in Adults with Hypermobile Disorders
  4. Hypermobile Ehlers-Danlos Syndrome, 2025 -- Foundational guidance on hEDS/HSD
  5. Frontiers, 2026 -- Linking Central Sensitization to Multisystemic Manifestations in hypermobile Ehlers-Danlos Syndrome
  6. Clinical Rheumatology — Establishing a Core Outcome Set for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Insights from a Delphi Consensus Approach
  7. Hypermobile Ehlers-Danlos Syndrome
  8. Frontiers | Linking Central Sensitization to Multisystemic Manifestations in hypermobile Ehlers-Danlos Syndrome
  9. Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features - PubMed

Original Source(s)

Related Content